Digital Therapeutics for Tinnitus Global Market Report 2025

The digital therapeutics for tinnitus market size has grown exponentially in recent years. It will grow from $1.4 billion in 2024 to $1.78 billion in 2025 at a compound annual growth rate (CAGR) of 27.4%. The growth during the historic period is attributed to the increasing prevalence of tinnitus, rising adoption of digital health solutions, growing awareness of tinnitus management, expanding healthcare digitization, and increasing demand for personalized treatment options.

The digital therapeutics for tinnitus market size is expected to see exponential growth in the next few years. It will grow to $4.64 billion in 2029 at a compound annual growth rate (CAGR) of 27.1%. The growth during the forecast period is attributed to a growing aging population, increasing cases of noise-induced hearing loss, rising healthcare expenditure, higher prevalence of chronic conditions, and growing demand for home-based healthcare solutions. Key trends in the forecast period include technological advancements, innovations in digital therapeutics, developments in neuromodulation therapies, increased investment in research and development, and integration of artificial intelligence in treatment.

The rising adoption of digital health solutions is expected to drive the growth of the digital therapeutics for tinnitus market in the coming years. Digital health encompasses the use of digital technologies, connected tools, and data-driven platforms to enhance healthcare delivery, improve patient outcomes, and support health management. Adoption is increasing as more people gain access to smartphones and the internet, enabling patients to connect with healthcare services anytime and anywhere. Digital therapeutics for tinnitus leverage this connectivity by providing mobile health apps, telemedicine platforms, and evidence-based interventions that are both accessible and convenient. For example, in December 2023, the UK National Health Service reported that digital health app users reached 33.6 million, up from 16.8 million in 2022, with monthly logins increasing 54% from 16.8 million to 25.8 million. This demonstrates that the growing adoption of digital health solutions is driving the digital therapeutics for tinnitus market.

Leading companies in the digital therapeutics for tinnitus market are focusing on innovations such as digital therapeutics for neuro-behavioral disorders to enhance auditory processing and mental health outcomes. Digital therapeutics for neuro-behavioral disorders are software-driven, evidence-based interventions designed to prevent, manage, or treat neurological and behavioral conditions, including tinnitus, depression, or anxiety, by delivering personalized digital programs that improve cognitive, emotional, or sensory functions. In February 2025, South Korea-based Neurive introduced SoriCLEAR, a digital therapeutic for tinnitus and depression. Developed under the leadership of CEO Jae-Jun Song, a Korea University professor specializing in neuromodulation, dementia, and depression, SoriCLEAR uses artificial intelligence to assess factors such as age, gender, tinnitus frequency, and severity, enabling personalized treatment plans for individual patients. SoriCLEAR has been approved by Korea’s Ministry of Food and Drug Safety as the country’s fifth digital therapeutic for tinnitus and is available for clinical use, offering a promising non-invasive treatment option.

In August 2024, Ireland-based Neuromod Devices partnered with the University of South Dakota Speech, Language, and Hearing Clinic to expand access to its Lenire bimodal neuromodulation device for tinnitus treatment. The University of South Dakota clinic provides assessment and therapy services for speech, language, and hearing disorders, and this partnership aims to broaden access to Neuromod Devices’ FDA-approved tinnitus treatment solution.

Major players in the digital therapeutics for tinnitus market are Sonova Holding AG, Starkey Hearing Technologies, Oticon A/S, ASKA Pharmaceutical Co. Ltd., Beltone, InfectoPharm Arzneimittel und Consilium GmbH, Signia, Oto Health Inc., Neuromod Devices Ltd., Mahana Therapeutics Inc., AudioCardio Inc., Neuromonics Inc., Treble Health Ltd., Sound Oasis LLC, AppyHapps Inc., Auricle Inc., TrueSilence Inc., MindEar Ltd., Tinnitracks, Tonal Tinnitus Therapy.

North America was the largest region in the digital therapeutics for tinnitus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics for the tinnitus report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics for tinnitus market research report is one of a series of new reports that provides digital therapeutics for tinnitus market statistics, including the digital therapeutics for tinnitus industry global market size, regional shares, competitors with the digital therapeutics for tinnitus market share, detailed digital therapeutics for tinnitus market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics for tinnitus industry. This digital therapeutics for tinnitus market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Digital therapeutics for tinnitus are evidence-based digital interventions designed to manage or alleviate the perception of tinnitus through software-driven therapies. These solutions use technologies such as mobile applications, artificial intelligence, and data analytics to deliver personalized sound therapy and behavioral support. They aim to enhance auditory health and overall well-being through continuous digital engagement and clinically validated therapeutic methods.

The primary product types of digital therapeutics for tinnitus include software applications, devices, and services. Software applications are clinically validated programs that provide therapeutic interventions to manage tinnitus symptoms and improve auditory health. These solutions employ therapies such as cognitive behavioral therapy, sound therapy, educational therapy, and others, and are distributed via online platforms, hospitals and clinics, and other channels. Key end users include adults, pediatric patients, and geriatrics.

The countries covered in the digital therapeutics for the tinnitus market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for the tinnitus market consist of revenues earned by entities by providing services such as remote therapy monitoring, teleconsultation support, data analytics and reporting services, patient engagement and coaching programmes and subscription-based therapy management. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for the tinnitus market include sales of wearable sound generators, smart headbands and earbuds, AI-powered therapy platforms, neurostimulation devices and virtual reality (VR) therapy systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.